Skip to content

NBIX

NEUROCRINE BIOSCIENCES INC

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US

$146.23
−3.69%
Ask drillr
0
Insider buys (3m)
12
Insider sells (3m)
-$7.9M
Net value (3m)
-8.1%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 15, 2026Lippoldt Darin · officer: Chief Legal OfficerA-Award4,483$0.00
Sep 15, 2026BENEVICH ERIC · officer: Chief Commercial OfficerA-Award6,275$0.00
Sep 15, 2026Boyer David W. · officer: Chief Corp. Affairs OfficerF-InKind1,936$156
Sep 15, 2026GORMAN KEVIN CHARLES · directorA-Award14,343$0.00
Sep 15, 2026Delaet Ingrid · officer: Chief Regulatory OfficerA-Award4,483$0.00
Sep 15, 2026Gano Kyle · director, officer: Chief Executive OfficerA-Award6,275$0.00
Sep 15, 2026Cooke Julie · officer: Chief Human Resources OfficerA-Award3,587$0.00
Sep 15, 2026Onyia Jude · officer: Chief Scientific OfficerF-InKind1,936$156
Sep 15, 2026BENEVICH ERIC · officer: Chief Commercial OfficerF-InKind3,386$156
Sep 15, 2026ABERNETHY MATT · officer: Chief Financial OfficerSale2,311$157
Sep 15, 2026Gano Kyle · director, officer: Chief Executive OfficerA-Award1,842$0.00
Sep 15, 2026ABERNETHY MATT · officer: Chief Financial OfficerF-InKind2,709$156
Sep 15, 2026Delaet Ingrid · officer: Chief Regulatory OfficerF-InKind2,419$156
Sep 15, 2026Boyer David W. · officer: Chief Corp. Affairs OfficerA-Award3,587$0.00
Sep 15, 2026Gano Kyle · director, officer: Chief Executive OfficerF-InKind994$156
Sep 15, 2026GORMAN KEVIN CHARLES · directorF-InKind7,839$156
Sep 15, 2026Boyer David W. · officer: Chief Corp. Affairs OfficerSale826$157
Sep 15, 2026Onyia Jude · officer: Chief Scientific OfficerA-Award3,587$0.00
Sep 15, 2026Keswani Sanjay Chandru · officer: Chief Medical OfficerF-InKind2,112$156
Sep 15, 2026Lippoldt Darin · officer: Chief Legal OfficerF-InKind2,419$156
Sep 15, 2026ABERNETHY MATT · officer: Chief Financial OfficerA-Award5,020$0.00
Sep 15, 2026Cooke Julie · officer: Chief Human Resources OfficerF-InKind1,936$156
Sep 15, 2026Gano Kyle · director, officer: Chief Executive OfficerF-InKind3,386$156
Sep 15, 2026Keswani Sanjay Chandru · officer: Chief Medical OfficerA-Award3,914$0.00
Sep 10, 2026BENEVICH ERIC · officer: Chief Commercial OfficerSale2,154$155
Sep 10, 2026BENEVICH ERIC · officer: Chief Commercial OfficerM-Exempt3,194$43
Jul 30, 2026Norwalk Leslie V · directorM-Exempt842$139
Jul 30, 2026Norwalk Leslie V · directorSale1,250$182
Jul 13, 2026Delaet Ingrid · officer: Chief Regulatory OfficerM-Exempt4,367$106
Jul 13, 2026Lippoldt Darin · officer: Chief Legal OfficerM-Exempt10,000$81
Institutional positioning

13F filings over the trailing two quarters

New 236Increased 615Reduced 453Sold out 67
FilerActionSharesFiled
BlackRock, Inc.Increased13,711,607Aug 7, 2026
BLACKROCK, INC.Increased13,385,607May 13, 2026
JPMORGAN CHASE & COIncreased6,398,674Aug 12, 2026
DODGE & COXIncreased5,584,707Aug 13, 2026
DODGE & COXReduced5,461,037May 14, 2026
JPMORGAN CHASE & COIncreased5,442,067May 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased4,974,083Aug 13, 2026
AQR CAPITAL MANAGEMENT LLCIncreased4,938,967May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position4,726,344May 8, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased4,545,339Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position4,511,904May 15, 2026
STATE STREET CORPIncreased4,385,598Aug 7, 2026
STATE STREET CORPIncreased4,354,526May 15, 2026
AQR CAPITAL MANAGEMENT LLCReduced3,818,037Aug 14, 2026
TWO SIGMA INVESTMENTS, LPIncreased3,060,570May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 15, 2026